Skip to main content
Clinical Trials/NL-OMON29401
NL-OMON29401RecruitingNot Applicable

Diabetying & lifestyle as medicine programme for people with diabetes type II in primary care – an implementation pilot

TNO0 sites16 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
16

Study Overview

Brief Summary

not applicable

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patient is newly diagnosed with T2D
  • •-Patient is about to start Metformin
  • •-Patient is about to start with a second oral drug (like SU-derivates)
  • •-Patient is about to start with an injectable drug (Insulin or GLP-1)
  • •Besides that, the patients should meet the following inclusion criteria:
  • •-Aged between 30-80 years
  • •-Have a BMI between 25-35 kg/m-2
  • •-Willing and able to sign the informed consent form
  • •-Able to fill in the 360-degree questionnaire which is in Dutch
  • •-Able to work with computers (e.g. for filling out questionnaires).

Exclusion Criteria

  • •-Dialysis patients
  • •-Possible limiting personal circumstances (e.g. unemployed, illness in the family, dept restructuring)
  • •-Patients under treatment of a psychiatrist
  • •-Incapacitated patients
  • •-Patients in a palliative phase

Investigators

Sponsor
TNO

Similar Trials